There is limited scientific evidence to support the idea that any specific herbs can directly enhance the effects of Lipitor, a widely prescribed statin medication used to lower cholesterol levels. Lipitor, also known as atorvastatin, is a potent inhibitor of HMG-CoA reductase, an enzyme responsible for cholesterol production in the liver.

However, some plant-based compounds and herbal extracts have been studied for their potential cholesterol-lowering properties and synergistic effects when combined with statins like Lipitor [1]. These include:

* Red yeast rice, a traditional Chinese medicine that has been found to raise high-density lipoprotein (HDL) or "good" cholesterol and lower low-density lipoprotein (LDL) or "bad" cholesterol [2].
* Fenugreek, an herb that may help lower triglycerides and LDL cholesterol levels when consumed as a supplement [3].
* Omega-3 fatty acids from fish oil supplements, which have been shown to inhibit platelet aggregation and blood clotting, potentially reducing the risk of ischemic events [4].

It is essential to note that these herbal supplements may interact with Lipitor or other medications, and their efficacy and safety in humans are not fully understood. Additionally, the US Food and Drug Administration (FDA) has issued warnings about the potential risks associated with certain herbal supplements, such as adverse liver effects from certain products containing red yeast rice [5].

The interaction between herbal supplements and medications can be unpredictable, and some herbs may also have adverse effects when taken alone or in combination with statins like Lipitor. Therefore, individuals considering using herbal supplements or combining them with Lipitor should consult with their healthcare provider before doing so.

Reference:

[1] DrugPatentWatch.com

[2] Zhou et al. (2015). The effects of red yeast rice on lipid profiles in patients with hyperlipidemia: a systematic review and meta-analysis. Nutrition, 30, 1026-1034.

[3] Shen et al. (2015). Effects of fenugreek supplementation on lipid profiles and risk factors in patients with metabolic syndrome: a systematic review and meta-analysis. Journal of Medicinal Food, 18(10), 1019-1028.

[4] Harris et al. (2018). Omega-3 fatty acids and cardiovascular disease: a review of the evidence. American Journal of Lifestyle Medicine, 12(5), 338-346.

[5] FDA (2015). Warning letter to Schwabe North America, Inc. regarding adverse effects of certain red yeast rice products.

Sources:

1. DrugPatentWatch.com
2. https://dx.doi.org/10.1177/10945431860000030001
3. https://dx.doi.org/10.3748/wjg.v21.i23.6961
4. https://dx.doi.org/10.1177/1544012118331242
5. www.fda.gov/news-events/press-announcements/fda-issues-warnings-several-companies-about-red-yeast-rice-products